The European Patent Office (EPO) has officially granted patent EP3513797B1, which pertains to a method for treating the effects of stroke. The patent, designated for a B1 kind, was granted on March 18, 2026. The inventors listed are Simon Andrea Koblar, Stan Gronthos, and Agnieszka Arthur. The patent covers specific International Patent Classifications (IPC) related to medicinal preparations, cell cultures, and therapeutic uses.

This grant signifies the EPO's recognition of novelty and inventiveness in the claimed method. While this is a patent grant and not a regulatory rule imposing direct compliance obligations on companies, it is crucial for pharmaceutical and biotechnology firms operating in the EU. Companies involved in stroke treatment research and development should be aware of this granted patent to ensure their activities do not infringe upon the intellectual property rights secured by the patent holder. No immediate compliance actions are required, but awareness is key for ongoing R&D and commercialization strategies.